Stay updated on CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies site revision v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-18T00:41:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-03T18:42:12.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces the transition from “Artificial Intelligence” to “Super Intelligence,” and the website revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.5%
    Check dated 2026-10-20T18:56:15.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-06T18:55:24.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the study's history, and the previous revision v3.6.6 is removed from the visible change set.
    Difference
    0.1%
    Check dated 2026-09-15T22:29:35.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history, replacing the previous v3.6.5. This reflects a metadata update to the record rather than a change to core study content.
    Difference
    0.1%
    Check dated 2026-09-01T18:24:47.000Z thumbnail image

Stay in the know with updates to CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.